Hebbar M - Search Results

1

Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patients.

Revillion F, Hebbar M, Bonneterre J, Peyrat JP. Revillion F, et al. Among authors: hebbar m. Eur J Cancer. 1996 Feb;32A(2):231-4. doi: 10.1016/0959-8049(95)00568-4. Eur J Cancer. 1996. PMID: 8664033

2

E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.

Hebbar M, Adenis A, Révillion F, Duhamel A, Romano O, Truant S, Libersa C, Giraud C, Triboulet JP, Pruvot FR, Peyrat JP. Hebbar M, et al. Eur J Cancer. 2009 Jul;45(10):1871-6. doi: 10.1016/j.ejca.2009.03.011. Epub 2009 Apr 8. Eur J Cancer. 2009. PMID: 19361981

3

The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.

Hebbar M, Révillion F, Louchez MM, Vilain MO, Fournier C, Bonneterre J, Peyrat JP. Hebbar M, et al. Clin Cancer Res. 1998 Feb;4(2):373-80. Clin Cancer Res. 1998. PMID: 9516925

4

Age as a prognostic factor in breast cancer.

Vanlemmens L, Hebbar M, Peyrat JP, Bonneterre J. Vanlemmens L, et al. Among authors: hebbar m. Anticancer Res. 1998 May-Jun;18(3B):1891-6. Anticancer Res. 1998. PMID: 9677440

5

Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients.

Hebbar M, Révillion F, Louchez MM, Fournier C, Bonneterre J, Peyrat JP. Hebbar M, et al. Clin Cancer Res. 1999 Jun;5(6):1427-33. Clin Cancer Res. 1999. PMID: 10389928

6

Significance of soluble endothelial molecule E-selectin in patients with breast cancer.

Hebbar M, Peyrat JP. Hebbar M, et al. Int J Biol Markers. 2000 Jan-Mar;15(1):15-21. doi: 10.1177/172460080001500103. Int J Biol Markers. 2000. PMID: 10763135 Free article.

7

Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay.

Pawlowski V, Révillion F, Hebbar M, Hornez L, Peyrat JP. Pawlowski V, et al. Among authors: hebbar m. Clin Cancer Res. 2000 Nov;6(11):4217-25. Clin Cancer Res. 2000. PMID: 11106235

8

Expression of nerve growth factor receptors and their prognostic value in human breast cancer.

Descamps S, Pawlowski V, Révillion F, Hornez L, Hebbar M, Boilly B, Hondermarck H, Peyrat JP. Descamps S, et al. Among authors: hebbar m. Cancer Res. 2001 Jun 1;61(11):4337-40. Cancer Res. 2001. PMID: 11389056

9

Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients.

Hebbar M, Krzewinski-Recchi MA, Hornez L, Verdière A, Harduin-Lepers A, Bonneterre J, Delannoy P, Peyrat JP. Hebbar M, et al. Int J Biol Markers. 2003 Apr-Jun;18(2):116-22. doi: 10.1177/172460080301800204. Int J Biol Markers. 2003. PMID: 12841680 Free article.

10

Association between systemic sclerosis and breast cancer: eight new cases and review of the literature.

Launay D, Le Berre R, Hatron PY, Peyrat JP, Hachulla E, Devulder B, Hebbar M. Launay D, et al. Among authors: hebbar m. Clin Rheumatol. 2004 Dec;23(6):516-22. doi: 10.1007/s10067-004-0940-5. Clin Rheumatol. 2004. PMID: 15801071 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters